This analysis details potential options strategies for BridgeBio Pharma Inc (BBIO), currently trading at $67.54. Selling a $65.00 strike put for a $7.20 premium offers an 11.08% return (25.92% annualized) if it expires worthless, with a 62% probability, effectively reducing the purchase cost to $57.80 if assigned. Alternatively, a covered call strategy involving buying BBIO shares and selling a $70.00 strike call for a $7.00 premium could yield a 14.01% total return if the stock is called away, or a 10.36% premium boost (24.26% annualized) if the call expires worthless, with a 46% probability. The implied volatilities for these options (63% for the put, 57% for the call) are noted against BBIO's 53% trailing 12-month actual volatility.
BridgeBio Pharma Inc (BBIO), currently trading at $67.54, presents opportunities for options-based income generation or discounted share acquisition. Selling a $65.00 strike put for a $7.20 premium offers a potential effective purchase price of $57.80 if assigned. This out-of-the-money contract has a 62% probability of expiring worthless, yielding an 11.08% return on cash commitment, or 25.92% annualized. For investors holding or initiating a position, a covered call strategy involves buying BBIO shares and selling the $70.00 strike call for a $7.00 premium. This could generate a 14.01% total return if shares are called away by April 2026. If the call expires worthless (46% probability), it provides a 10.36% premium boost, or 24.26% annualized. The implied volatility for the put (63%) and call (57%) both exceed BBIO's trailing twelve-month actual volatility of 53%. This indicates the options market anticipates higher future price fluctuations than recent historical data. The overall sentiment surrounding these strategies is mildly positive, with a neutral tone, suggesting a balanced risk-reward outlook.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment
